Home > Insider Trading > Filing (0000950170-25-045583)

Filing Details

Accession Number:: 0000950170-25-045583
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-26 19:21:46
Reporting Period:: 2025-03-24

Filing Date:: 2025-03-26
Accepted Time:: 2025-03-26 19:21:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832332	Aveanna Healthcare Holdings Inc.	AVAH	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1567459	J.h. Whitney Equity Partners Vii, Llc	212 Elm Street New Canaan CT 06840		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Disposition	2025-03-24	173	$5.63	31,387,986	No	4	S	Indirect	By J.H. Whitney VII, L.P.
Common Stock, $0.01 Par Value	Disposition	2025-03-25	116	$5.64	31,387,870	No	4	S	Indirect	By J.H. Whitney VII, L.P.
Common Stock, $0.01 Par Value	Disposition	2025-03-24	87	$5.63	15,681,774	No	4	S	Indirect	By PSA Healthcare Investment Holding LLC
Common Stock, $0.01 Par Value	Disposition	2025-03-25	58	$5.64	15,681,716	No	4	S	Indirect	By PSA Healthcare Investment Holding LLC
Common Stock, $0.01 Par Value	Disposition	2025-03-24	8	$5.63	1,451,770	No	4	S	Indirect	By PSA Iliad Holdings LLC
Common Stock, $0.01 Par Value	Disposition	2025-03-25	5	$5.64	1,451,765	No	4	S	Indirect	By PSA Iliad Holdings LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By J.H. Whitney VII, L.P.
No	4	S	Indirect	By J.H. Whitney VII, L.P.
No	4	S	Indirect	By PSA Healthcare Investment Holding LLC
No	4	S	Indirect	By PSA Healthcare Investment Holding LLC
No	4	S	Indirect	By PSA Iliad Holdings LLC
No	4	S	Indirect	By PSA Iliad Holdings LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	0	Direct

Footnotes

The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.